In August 2022, researchers from the Quebec Heart and Lung Institute, University of Pennsylvania, U.S. Food and Drug Administration, Columbia University, University of Washington Medical Center, Beaumont Hospital, Guy’s and St Thomas’ N.H.S. Foundation Trust, Cambridge University and King’s College Hospital, University of Edinburgh (B.H.F. Centre for Cardiovascular Science), St Paul’s and Vancouver General Hospital,…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest